Scientists map the hidden timeline of a deadly hantavirus
NCT ID NCT07703579
First seen Jul 14, 2026 · Last updated Jul 15, 2026 · Updated 1 time
Summary
This observational study follows people who have been exposed to Andes virus, a hantavirus that can cause severe respiratory illness. Researchers collect blood samples and monitor symptoms at key points from exposure through infection and recovery. The goal is to understand how the virus behaves in the body and how the immune system responds, without directing any medical care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could reveal key patterns in how Andes virus infection progresses, helping design better treatments or vaccines for hantavirus diseases.
- What could go wrong
- This is a small observational study with only 15 participants, so findings may not apply broadly. It does not test any treatment, so it cannot directly improve patient outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANDES HANTAVIRUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hôpital Bichat
Paris, 75018, France
-
Hôpital Pellegrin
Bordeaux, 75018, France
-
La Pitié Salpêtrière
Paris, 75018, France